Avitas Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$2.84M Sell
5,455
-1,016
-16% -$529K 0.39% 65
2024
Q3
$4M Buy
6,471
+100
+2% +$61.9K 0.56% 45
2024
Q2
$3.52M Buy
6,371
+12
+0.2% +$6.64K 0.52% 52
2024
Q1
$3.7M Buy
6,359
+1,309
+26% +$761K 0.56% 45
2023
Q4
$2.68M Buy
5,050
+140
+3% +$74.3K 0.45% 57
2023
Q3
$2.49M Sell
4,910
-42
-0.8% -$21.3K 0.47% 57
2023
Q2
$2.58M Buy
4,952
+22
+0.4% +$11.5K 0.47% 57
2023
Q1
$2.84M Sell
4,930
-62
-1% -$35.7K 0.56% 49
2022
Q4
$2.75M Sell
4,992
-59
-1% -$32.5K 0.58% 51
2022
Q3
$2.56M Buy
5,051
+27
+0.5% +$13.7K 0.59% 52
2022
Q2
$2.73M Buy
5,024
+48
+1% +$26.1K 0.6% 50
2022
Q1
$2.94M Sell
4,976
-7,973
-62% -$4.71M 0.53% 59
2021
Q4
$8.64M Buy
12,949
+192
+2% +$128K 1.45% 12
2021
Q3
$7.29M Sell
12,757
-31
-0.2% -$17.7K 1.33% 13
2021
Q2
$6.45M Buy
12,788
+247
+2% +$125K 1.15% 19
2021
Q1
$5.72M Buy
12,541
+289
+2% +$132K 1.12% 17
2020
Q4
$5.71M Buy
12,252
+214
+2% +$99.7K 1.16% 12
2020
Q3
$5.32M Buy
12,038
+97
+0.8% +$42.8K 1.48% 9
2020
Q2
$4.33M Sell
11,941
-335
-3% -$121K 1.44% 13
2020
Q1
$3.48M Sell
12,276
-2,251
-15% -$638K 1.58% 18
2019
Q4
$4.72M Buy
14,527
+44
+0.3% +$14.3K 1.21% 15
2019
Q3
$4.22M Buy
14,483
+189
+1% +$55K 1.16% 19
2019
Q2
$4.2M Sell
14,294
-36
-0.3% -$10.6K 1.17% 19
2019
Q1
$3.92M Buy
14,330
+136
+1% +$37.2K 1.14% 23
2018
Q4
$3.18M Buy
14,194
+4,022
+40% +$900K 1.04% 31
2018
Q3
$2.48M Buy
10,172
+381
+4% +$93K 0.71% 65
2018
Q2
$2.03M Buy
+9,791
New +$2.03M 0.63% 75